Latest issue of Hampshire & IOW Medicines Optimisation Bulletin

Issue 96 Provided by Hampshire & Isle of Wight ICB

The latest bulletin contains information on the following:

  • MHRA Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate
  • mega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose[1]dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors
  • The British HIV Association (BHIVA) rapid guidance on the use of statins for primary prevention of cardiovascular disease (CVD) in people living with HIV
  • UKHSA: Emergence of new Clostridioides difficile ribotype
  • The NEWT Guidelines for swallowing difficulties
  • National measles guidelines updated
  • SPS: St. Mark’s electrolyte solution
  • Menopause Pathway – Guidance on management and prescribing choices.
  • Shortage of lidocaine 1% (or 2%) with adrenaline 1:200 000
  • Levetiracetam granules
  • Suspected sepsis: recognition, diagnosis and early management – updated guidance (NG51)
  • Educational Webinar - medicines optimisation in people with a learning disability and/or autism
  • Pharmacy First launches
  • Emergency ordering service for community pharmacies for fidaxomicin to treat Clostridioides difficile infection (CDI)

Download the bulletin here for more information and links: